Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2025: USD 6.45 B

Elevance Health Inc. Operating Cash Flow is USD 6.45 B for the Trailing 12 Months (TTM) ending June 30, 2025, a 212.24% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 2.07 B, a -82.52% change year over year.
  • Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 11.82 B, a 28.97% change year over year.
  • Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 9.17 B, a 33.83% change year over year.
  • Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 6.85 B, a -37.83% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities